Gene · 8242
Papers1,955
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,955
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Genomic Profiling Across Diverse Solid Tumors: A Real-World Experience From India With FoundationOne®CDx Testing. | Cureus | 2026 | 41717185 | PubTator, text mining | PubMed |
| Dysregulated post‑translational modifications in granulosa cells drive ovarian dysfunction and potential infertility applications (Review). | Int J Mol Med | 2026 | 41716015 | PubTator, text mining | PubMed |
| ERRα-KDM5C restrains STING enhancer activity to modulate type I interferon signaling in breast cancer progression. | Cell Death Dis | 2026 | 41708589 | PubTator, text mining | PubMed |
| Reversible arginine methylation regulates mitochondrial IDH2 activity: coordinated control by CARM1 and KDM3A/4A. | Cell Death Dis | 2026 | 41629283 | PubTator, text mining | PubMed |
| An exploratory study on the relationship between renal cell carcinoma and CAFs infiltration by integrating Pathomics and collagen features. | Transl Oncol | 2026 | 41579564 | PubTator, text mining | PubMed |
| Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data. | JCO Precis Oncol | 2026 | 41576306 | PubTator, text mining | PubMed |
| Characterization of ESR1 alterations in patients with breast and gynecologic cancers. | Breast Cancer Res | 2026 | 41555446 | PubTator, text mining | PubMed |
| A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers. | ESMO Open | 2026 | 41547215 | PubTator, text mining | PubMed |
| NF1/2 mutations predict favorable benefit from immune checkpoint inhibitor-based therapies over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma. | Clin Exp Med | 2026 | 41546842 | PubTator, text mining | PubMed |
| Individuals with reported and novel KDM5C variants present with seizures, a feature recapitulated in a Drosophila model. | Hum Mol Genet | 2026 | 41537560 | PubTator, text mining | PubMed |
| Identification of Bruceine A as a novel HSP90AB1 inhibitor for suppressing hepatocellular carcinoma growth. | J Adv Res | 2026 | 40664262 | PubTator, text mining | PubMed |
| Xist in X chromosome inactivation: mechanisms and disease relevance. | Cell Commun Signal | 2025 | 41430272 | PubTator, text mining | PubMed |
| Multi-omics elucidation of KDM5C, KDM6A, and KMT2B roles in cancer epigenetic dysregulation and transcriptional reprogramming. | Commun Biol | 2025 | 41331063 | PubTator, text mining | PubMed |
| JC Virus Agnogene Regulates Histone-Modifying Enzymes via PML-NBs: Transcriptomics in VLP-Expressing Cells. | Viruses | 2025 | 41157668 | PubTator, text mining | PubMed |
| Tumor Microenvironment T-cell Heterogeneity and Prognostic Model Construction in Laryngeal Squamous Cell Carcinoma by Single-cell and Bulk RNA Sequencing. | Comput Methods Biomech Biomed Engin | 2025 | 41066764 | PubTator, text mining | PubMed |
| Roles of KDM5 demethylases in therapeutic resistance of cancers. | Epigenetics Chromatin | 2025 | 41013520 | PubTator, text mining | PubMed |
| Individuals with reported and novel KDM5C variants present with seizures, a feature recapitulated in a Drosophila model. | medRxiv | 2025 | 41001479 | PubTator, text mining | PubMed |
| Requirements for establishment and epigenetic stability of mammalian heterochromatin. | Mol Cell | 2025 | 40972525 | PubTator, text mining | PubMed |
| Epigenetic relay: Polycomb-directed DNA methylation in mammalian development. | PLoS Genet | 2025 | 40953013 | PubTator, text mining | PubMed |
| KDM5C: A dual-edged epigenetic regulator in cancer biology-context-dependent roles and therapeutic implications. | Biochem Pharmacol | 2025 | 40945540 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8242/papers?page=3